Wechselkurs , Währungsrechner

English Français Deutsch Español 日本語 한국의 繁體简体 Português Italiano Русский हिन्दी ไทย Indonesia Filipino Nederlands Dansk Svenska Norsk Ελληνικά Polska Türkçe العربية

Warning: include_once(../cacheforex2/de/00curr_de.html): Failed to open stream: No such file or directory in /www/wwwroot/exchangerateeuro.org/exchange-rate-converter.php on line 146

Warning: include_once(): Failed opening '../cacheforex2/de/00curr_de.html' for inclusion (include_path='.:') in /www/wwwroot/exchangerateeuro.org/exchange-rate-converter.php on line 146

US Dollar(USD) Wechselkurse

1	USD	=	3.9676	PLN
10	USD	=	39.676	PLN
100	USD	=	396.76	PLN
1000	USD	=	3967.6	PLN
10000	USD	=	39676	PLN

Informationen werden zu Informationszwecken und nicht zum Handel oder zur Beratung, und kann sich leicht verzögern.

Installieren Free USD Wechselkurse!

Installieren Free Währungsrechner!

freien Währungsrechner:

Farbe auswählen:
Zeitzone:
Datumsformat:

US Dollar Währungsrechner

Währungsrechner

<style type="text/css">#fx_convert_1 br {display:none;}</style><div style="width:160px;text-align:center;" id="fx_convert_1"><div id="xcolorc1_1" style="border:1px solid #000;background-color:#94abf0;padding: 0px 0px;margin: 0px 0px;align:center;overflow:hidden;"><div id="xcolorc1_2" style="font-size:12px;color:#183a00;line-height:16px;font-family: arial; font-weight:bold;background:#94abf0;padding: 3px 1px;text-align:center;"><a href="http://www.exchangerateeuro.org/USD" alt="USD US Dollar Währungsrechner" title="USD US Dollar Währungsrechner" id="forex2_linkc1" style="color:#000000;font-size:14px;text-decoration:none;line-height:16px;font-family: arial;" ><img src="http://www.exchangerateeuro.org/images/USD.gif" border="0" style="margin:0;padding:0;border:0;" />US Dollar Währungsrechner</a></div><script src="http://www.exchangerateeuro.org/z.php?z=de_USDc1&c=94abf0&tz=Europe/Berlin&tf=1"></script></div><div style="text-align:center;"><a href="http://www.exchangerateeuro.org/" style="font-size:12px;">Währungsrechner</a></div></div>

More USD Wechselkurse!

Wechselkurse Rechner:

Farbe auswählen:
Zeitzone:
Datumsformat:

US Dollar Wechselkurse

Wechselkurse

More Free Währungsrechner Widget!

Wechselkurse:

Deprecated: Creation of dynamic property lastRSS::$cache_dir is deprecated in /www/wwwroot/exchangerateeuro.org/00rss.php on line 45

Deprecated: Creation of dynamic property lastRSS::$cache_sqlite is deprecated in /www/wwwroot/exchangerateeuro.org/00rss.php on line 46

Deprecated: Creation of dynamic property lastRSS::$cache_time is deprecated in /www/wwwroot/exchangerateeuro.org/00rss.php on line 47

Deprecated: Creation of dynamic property lastRSS::$rsscp is deprecated in /www/wwwroot/exchangerateeuro.org/lastRSS.php on line 234

Adjuvant Olaparib for Patients with BRCA1- or BRCA2-Mutated . . .
Poly (adenosine diphosphate–ribose) polymerase inhibitors target cancers with defects in homologous recombination repair by synthetic lethality New therapies are needed to reduce recurrence in
OlympiA: Game Changer for Breast Cancer Treatment | NEJM . . .
For patients receiving adjuvant chemotherapy, high risk was defined as TNBC stage ≥pT2 or ≥pN1 or ER positive with ≥4 positive nodes Most patients (94%) received an anthracycline taxane
Table 7, Details of the OlympiA Study - Olaparib (Lynparza . . .
There were 2 exceptions The first was adequately treated nonmelanoma skin cancer, curatively treated in situ cancer of the cervix, DCIS, or stage I grade 1 endometrial carcinoma
OlympiA: A phase III, multicenter, randomized, placebo . . .
Eligible pts with TNBC had ≥pT2 or ≥pN1 disease prior to ACT or non-pCR after NACT; those with HR+ BC had ≥4 positive nodes prior to ACT or non-pCR and CPS EG score ≥3 after NACT
Clinicopathological characteristics and eligibility for . . .
In this study, we sought to characterize the real-world proportion of gBRCA1 2 PV carriers eligible for adjuvant olaparib according to the OlympiA criteria, and to compare clinicopathologic
OlympiA: A randomized phase III trial of olaparib as adjuvant . . .
Pts with hormone receptor (HR) positive BC must have ≥4 positive lymph nodes in the adjuvant and non-pCR and CPS EG score ≥3 in the neoadjuvant setting Pts must also harbor a deleterious gBRCAm
LBA1 Plenary Session OlympiA: A phase III, multicenter . . .
Eligible pts with TNBC had $pT2 or $pN1 disease prior to ACT or non-pCR after NACT; those with HR+ BC had $4 positive nodes prior to ACT or non-pCR and CPS EG score $3 after NACT